Endoscopy Assisted Probing Versus Simple Probing in Primary Congenital Nasolacrimal Duct Obstruction
Non
1 other identifier
interventional
320
1 country
1
Brief Summary
The aim of this study is to compare results of endoscopy assisted nasolacrimal probing with the standard simple probing in cases with congenital nasolacrimal duct obstruction . Furthermore, investigators will identify associated anatomical anomalies. Investigators believe results of this study can be valuable in better understanding of this disease and provide a high evidence level necessary to propose a classification and management algorithm. Children with symptoms of unilateral or bilateral congenital nasolacrimal duct obstruction, no past surgical management, with one or more of the below criteria will be included:
- 1.Non-resolving symptoms of epiphora and/or discharge.
- 2.Congenital dacryocele not resolved after 1 week of lacrimal sac massage, and topical antibiotics.
- 3.As soon as subsidence of acute dacryocystitis. Parents will be asked about symptoms and patients will undergo lacrimal tests before and after operation in one week, one month and 3months based on a special record form. Patients will be randomly assigned to "simple probing" group or "endoscopy assisted probing" group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 20, 2017
CompletedFirst Submitted
Initial submission to the registry
July 23, 2017
CompletedFirst Posted
Study publicly available on registry
August 8, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2020
CompletedOctober 10, 2019
March 1, 2019
2.5 years
July 23, 2017
October 9, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
success rate
absence of epiphora and discharge and negative dye disappearance test
6 months
Secondary Outcomes (1)
Incidence of Treatment-Emergent Adverse Events
6 month
Study Arms (2)
Endoscopy Assisted Probing
EXPERIMENTALEndoscopy Assisted Probing
Simple Probing
ACTIVE COMPARATORSimple Probing
Interventions
The patency of the system will be tested by irrigation with 1 ml normal saline. A cannula was introduced via the upper or lower canaliculus as far as the lacrimal sac and fluid injected through the system from a 5 ml syringe. Nasal endoscopy and irrigation will be performed simultaneously and free flow of fluid from the lacrimal sac to the nose will confirm anatomical patency of the system
Eligibility Criteria
You may qualify if:
- age: 3 weeks\<Age\<6 years
- epiphora or discharge since birth or within 8 weeks after birth
You may not qualify if:
- Follow up less than 3 months
- Epiphora secondary to etiologies than congenital naso-lacrimal duct obstruction such as puncta/canalicular aplasia/dysgenesis;midfacial anomalies; congenital eyelid malposition;epiblepharon; trichiasis; congenital glaucoma, tumors; blepharitis; trauma Treatment success: defined success absence of epiphora/lacrimation and discharge 6 months after intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Farzad Pakdel
Tehran, Iran
Study Officials
- PRINCIPAL INVESTIGATOR
Farzad Pakdel, M.D.
Farabi Hospital, Tehran University of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2017
First Posted
August 8, 2017
Study Start
July 20, 2017
Primary Completion
February 1, 2020
Study Completion
July 1, 2020
Last Updated
October 10, 2019
Record last verified: 2019-03